(Total Views: 426)
Posted On: 12/03/2019 1:10:51 PM
Post# of 76
$SNGX News Article - Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX301 in the Treatment of Cutaneous T-cell Lymphoma https://marketwirenews.com/news-releases/soli...41935.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
